MEDICLIN Aktiengesellschaft (MED)
Deutsche Börse Xetra · Germany · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 5.300 |
|---|---|
| 52-week range | 3.220 – 5.800 |
| Return, 1 month / 3 months | −0.9% / +27.4% |
| Return, 1 year / 3 years | +45.6% / +104.1% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 53 |
| Volatility (1 year) | 35.9% |
| Worst drawdown (1 year) | -17.4% |
| Average daily value traded | 0.04M EUR |
| Dividend yield | 0.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
MEDICLIN Aktiengesellschaft is a German healthcare provider that runs hospitals, rehabilitation clinics and care facilities, mainly in Germany. It treats patients needing acute medical care, follow-up rehabilitation and long-term nursing, working with referring doctors, health insurers and public health systems. The company is based in Germany and serves patients across its network of medical and care sites, combining inpatient hospital treatment with rehabilitation and elderly care services.
The shares are listed on the Deutsche Börse Xetra in Germany under the code MED, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
MEDICLIN Aktiengesellschaft (MED) trades on the Deutsche Börse Xetra in Germany. It last closed at EUR 5.300 on 27 October 2026.
Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 136 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 45.6% and over the last three months it rose 27.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Deutsche Börse Xetra
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 90 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 25.9% | ||
| From 52-week high | -7.0% | ||
| Momentum | 92 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 27.4% | ||
| 6-month return | 53.9% | ||
| 12-month return, skipping the last month | 46.9% | ||
| Stability (higher is calmer) | 67 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 35.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.4% | ||
| Liquidity | 32 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.04M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 10 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.8% | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −1.9% |
|---|---|
| 1 month | −0.9% |
| 3 months | +27.4% |
| 6 months | +53.9% |
| 1 year | +45.6% |
| 3 years | +104.1% |
| 5 years | +35.8% |
Signals
| 50-day / 200-day average | 5.343 / 4.208 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.199 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 May 2026 | EUR 0.0400 |
| 5 Jun 2025 | EUR 0.0400 |
| 30 May 2019 | EUR 0.0500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Deutsche Börse Xetra; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.